Luye Pharma Group (LUP) Revenue
Luye Pharma Group Revenue
Luye Pharma Group had a revenue of 3.00B in the quarter ending Jun 30, 2026, with -4.00%. This bring the company's revenue in the last twelve months to 6.13B, Decreased 2.84%. In the fiscal year ending Dec 31, 2025, Luye Pharma Group had annual revenue of 6.31B with 4.07% growth.
- Revenue (ttm)
- 6.13B
- Revenue Growth
- -4.39%
- P/S Ratio
- 0.11
- Revenue/Employee
- EUR 1,197,035
- Employees
- 5,270
- Market Cap
- EUR 710.95M
Revenue Chart
Luye Pharma Group Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.31B | 246.93M | 4.07% |
| Dec 31, 2024 | 6.06B | -81.64M | -1.33% |
| Dec 31, 2023 | 6.14B | 161.42M | 2.70% |
| Dec 31, 2022 | 5.98B | 781.43M | 15.03% |
| Dec 31, 2021 | 5.20B | -339.42M | -6.13% |
| Dec 31, 2020 | 5.54B | -817.96M | -12.87% |
| Dec 31, 2019 | 6.36B | 1.18B | 22.89% |
| Dec 31, 2018 | 5.17B | 1.36B | 35.61% |
| Dec 31, 2017 | 3.81B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.